ChartMill assigns a Buy % Consensus number of 83% to LIPO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-09 | Maxim Group | Initiate | Buy |
7 analysts have analysed LIPO and the average price target is 10.2 USD. This implies a price increase of 332.2% is expected in the next year compared to the current price of 2.36.
The consensus rating for LIPELLA PHARMACEUTICALS INC (LIPO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering LIPELLA PHARMACEUTICALS INC (LIPO) is 7.